Efficiency and side effects of anti-CD38 CAR T cells in an adult patient with relapsed B-ALL after failure of bi-specific CD19/CD22 CAR T cell treatment.

Efficiency and side effects of anti-CD38 CAR T cells in an adult patient with relapsed B-ALL after failure of bi-specific CD19/CD22 CAR T cell treatment.
Cell Mol Immunol. 2020 Jan 03;:
Authors: Guo Y, Feng K, Tong C, Jia H, Liu Y, Wang Y, Ti D, Yang Q, Wu Z, Han W
PMID: 31900459 [PubMed - as supplied by publisher]

Source: Cellular and Molecular Immunology - January 2, 2020 Category: Molecular Biology Authors: Guo Y, Feng K, Tong C, Jia H, Liu Y, Wang Y, Ti D, Yang Q, Wu Z, Han W Tags: Cell Mol Immunol Source Type: research